AI's impact on pharma and compliance functions
During the panel, “Utilize AI to Enhance Oversight, Efficiency and Risk Mitigation,” Laham addressed the current state of AI adoption, ...
Read the original at BioXconomy ↗
- Topics
- Regulation & PolicyHealthcareGovernance & Risk Management
- Tracked via
- “AI Risks”